Der Artikel ist weiterhin als ^^OTHERCONDITION^^ verfügbar.
Autor: Regine Eibl
ISBN-13: 9783540681823
Einband: eBook
Seiten: 363
Sprache: Englisch
eBook Typ: PDF
eBook Format: eBook
Kopierschutz: Adobe DRM [Hard-DRM]
Systemvoraussetzungen
Der Artikel wird am Ende des Bestellprozesses zum Download zur Verfügung gestellt.

Cell and Tissue Reaction Engineering

Principles and Practice
Geben Sie Ihre Bewertung ab!  
Wir verlosen jeden Monat unter allen freigegebenen Rezensionen
3 Gutscheine im Wert von 20 Euro. Teilnahmebedingungen
The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells (“cells as product”) for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere.
Mammalian cell products such as monoclonals and cytokines dominate the biopharmaceutical industry. This book explores the interactions between biological, biochemical and engineering principles in processes derived from cell cultures.
The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells (“cells as product”) for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere.
Part I: Mammalian cells 1. Mammalian cell culture technology – an emerging field (Dieter Eibl, Regine Eibl, Ralf Pörtner) 2. Characteristics of mammalian cells and requirements for cultivation (Ralf Pörtner) 3. Bioreactors for mammalian cells – General overview (Dieter Eibl, Regine Eibl) 4. Special engineering aspects (Peter Czermak, Ralf Pörtner) 5. Bioreactor design and scale-up (Gerado Catapano, Peter Czermak, Regine Eibl, Dieter Eibl, Ralf Pörtner) Part II: Special applications 6. Insect cell-based recombinant protein production (Martin Fussenegger, Winfried Weber) 7. Bioreactors for bioartificial organs (Gerardo Catapano) 8. Plant cell-based bioprocessing (Dieter Eibl, Regine Eibl)

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.

 

Rezensionen

Autor: Regine Eibl
ISBN-13 :: 9783540681823
ISBN: 3540681825
Erscheinungsjahr: 26.09.2008
Verlag: Springer Berlin
Seiten: 363
Sprache: Englisch
Auflage 2009
Sonstiges: Ebook